156 related articles for article (PubMed ID: 36720562)
1. Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands.
Kager CC; Horsselenberg M; Korevaar JC; Wagner C; Hek K
BJGP Open; 2023 Mar; 7(1):. PubMed ID: 36720562
[TBL] [Abstract][Full Text] [Related]
2. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
3. Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study.
Grymonprez M; De Backer TL; Capiau A; Vauterin D; Mehuys E; Boussery K; Steurbaut S; Lahousse L
Br J Clin Pharmacol; 2023 Apr; 89(4):1360-1373. PubMed ID: 36321924
[TBL] [Abstract][Full Text] [Related]
4. Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry.
Wagner B; Hert L; Polymeris AA; Schaedelin S; Lieb JM; Seiffge DJ; Traenka C; Thilemann S; Fladt J; Altersberger VL; Zietz A; Dittrich TD; Fisch U; Gensicke H; De Marchis GM; Bonati LH; Lyrer PA; Engelter ST; Peters N
Front Neurol; 2022; 13():964723. PubMed ID: 36203998
[TBL] [Abstract][Full Text] [Related]
5. Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
Zielinski GD; van Rein N; Teichert M; Klok FA; Rosendaal FR; van der Meer FJM; Huisman MV; Cannegieter SC; Lijfering WM
Res Pract Thromb Haemost; 2020 Jan; 4(1):141-153. PubMed ID: 31989096
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
7. The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation.
van den Dries CJ; van Doorn S; Souverein P; Pajouheshnia R; Moons KGM; Hoes AW; Geersing GJ; van den Ham HA
TH Open; 2020 Oct; 4(4):e417-e426. PubMed ID: 33376941
[No Abstract] [Full Text] [Related]
8. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
[TBL] [Abstract][Full Text] [Related]
9. Oral Anticoagulants after Heart Transplantation-Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants.
Darche FF; Fabricius LC; Helmschrott M; Rahm AK; Ehlermann P; Bruckner T; Sommer W; Warnecke G; Frey N; Rivinius R
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445369
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study.
Hammoudeh AJ; Khader Y; Kadri N; Al-Mousa E; Badaineh Y; Habahbeh L; Tabbalat R; Janabi H; Alhaddad IA
Int J Vasc Med; 2021; 2021():5515089. PubMed ID: 33898065
[TBL] [Abstract][Full Text] [Related]
11. Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.
Stolk LM; de Vries F; Ebbelaar C; de Boer A; Schalekamp T; Souverein P; Ten Cate-Hoek A; Burden AM
Br J Clin Pharmacol; 2017 Aug; 83(8):1835-1843. PubMed ID: 28326589
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulant switching in patients with atrial fibrillation: a scoping review.
Adelakun AR; Turgeon RD; De Vera MA; McGrail K; Loewen PS
BMJ Open; 2023 Apr; 13(4):e071907. PubMed ID: 37185198
[TBL] [Abstract][Full Text] [Related]
14. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study.
Zapata-Wainberg G; Masjuan J; Quintas S; Ximénez-Carrillo Á; García Pastor A; Martínez Zabaleta M; Cardona P; Freijo Guerrero MM; Llull L; Benavente Fernández L; Castellanos Rodrigo M; Egido J; Serena J; Vivancos J;
Eur J Neurol; 2019 Feb; 26(2):230-237. PubMed ID: 30153363
[TBL] [Abstract][Full Text] [Related]
15. Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis.
Grymonprez M; Simoens C; Steurbaut S; De Backer TL; Lahousse L
Europace; 2022 Jul; 24(6):887-898. PubMed ID: 34935033
[TBL] [Abstract][Full Text] [Related]
16. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
17. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis.
Latif F; Nasir MM; Meer KK; Farhan SH; Cheema HA; Khan AB; Umer M; Rehman WU; Ahmad A; Khan MA; Almas T; Mactaggart S; Nashwan AJ; Ahmed R; Dani SS
Int J Cardiol Cardiovasc Risk Prev; 2024 Jun; 21():200282. PubMed ID: 38766665
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist-led interventions in optimising the use of oral anticoagulants in patients with atrial fibrillation in general practice in England: a retrospective observational study.
Sharma R; Hasan SS; Gilkar IA; Hussain WF; Conway BR; Ghori MU
BJGP Open; 2024 Apr; ():. PubMed ID: 38097269
[TBL] [Abstract][Full Text] [Related]
20. Trends in oral anticoagulant prescription in patients with nonvalvular atrial fibrillation in Flanders and the impact of switching patients from vitamin K antagonists to DOACS in terms of the burden caused by complications of the disease: a registry-based study.
Nakhoul E; Vaes B; Mamouris P; Degryse JM
Acta Clin Belg; 2023 Aug; 78(4):261-269. PubMed ID: 36172878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
